Jay Shepard - 15 Jan 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Jay P. Shepard
Issuer symbol
INO
Transactions as of
15 Jan 2023
Net transactions value
$0
Form type
4
Filing time
17 Jan 2023, 15:05:12 UTC
Previous filing
03 Jun 2022
Next filing
16 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +4,273 +12% 39,521 15 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -4,273 -100% $0.000000* 0 15 Jan 2023 Common Stock 4,273 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares vested on January 15, 2021; 4,274 shares vested on January 15, 2022; 4,273 shares vested on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both